|
PSME4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.052950E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.441540E-02 |
| Normal-vs-Stage2 |
4.457800E-01 |
| Normal-vs-Stage3 |
2.581800E-01 |
| Normal-vs-Stage4 |
5.172000E-01 |
| Stage1-vs-Stage2 |
3.771800E-01 |
| Stage1-vs-Stage3 |
1.611570E-01 |
| Stage1-vs-Stage4 |
1.762020E-02 |
| Stage2-vs-Stage3 |
9.706400E-01 |
| Stage2-vs-Stage4 |
2.668800E-01 |
| Stage3-vs-Stage4 |
1.476550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.969800E-02 |
| Normal-vs-AfricanAmerican |
4.778200E-01 |
| Normal-vs-Asian |
4.224500E-02 |
| Caucasian-vs-AfricanAmerican |
6.261800E-01 |
| Caucasian-vs-Asian |
3.402300E-02 |
| AfricanAmerican-vs-Asian |
6.540300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.058500E-02 |
| Normal-vs-Female |
4.072400E-01 |
| Male-vs-Female |
2.540200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.640600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.138400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.224100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.085440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.643800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.443000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.216000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.002200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.173000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.311600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.423900E-02 |
| Normal-vs-Grade 2 |
2.873800E-02 |
| Normal-vs-Grade 3 |
8.823700E-02 |
| Normal-vs-Grade 4 |
2.175000E-01 |
| Grade 1-vs-Grade 2 |
4.798600E-01 |
| Grade 1-vs-Grade 3 |
3.463800E-01 |
| Grade 1-vs-Grade 4 |
6.922100E-02 |
| Grade 2-vs-Grade 3 |
5.608400E-01 |
| Grade 2-vs-Grade 4 |
4.979500E-03 |
| Grade 3-vs-Grade 4 |
1.302210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.675170E-03 |
| Normal-vs-ccB subtype |
8.961800E-01 |
| ccA subtype-vs-ccB subtype |
7.75100000000029E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.197800E-01 |
| Normal-vs-N1 |
2.138200E-01 |
| N0-vs-N1 |
7.426000E-02 |
|
|
